Woodstock Corp Cuts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Woodstock Corp decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,619 shares of the medical equipment provider’s stock after selling 1,653 shares during the quarter. Intuitive Surgical comprises 3.2% of Woodstock Corp’s holdings, making the stock its 6th largest holding. Woodstock Corp’s holdings in Intuitive Surgical were worth $36,950,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Tobam increased its stake in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at about $27,000. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $554.58 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm’s 50-day simple moving average is $534.09 and its two-hundred day simple moving average is $505.41. The firm has a market cap of $198.81 billion, a price-to-earnings ratio of 73.36, a P/E/G ratio of 5.14 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In related news, insider Gary S. Guthart sold 28,800 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 4,500 shares of the business’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Piper Sandler increased their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Leerink Partners boosted their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn upped their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $609.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.